Prognostic Significance of Erythropoietin in Pancreatic Adenocarcinoma

BACKGROUND: Erythropoietin (Epo) administration has been reported to have tumor-promoting effects in anemic cancer patients. We investigated the prognostic impact of endogenous Epo in patients with pancreatic ductal adenocarcinoma (PDAC). METHODOLOGY: The clinico-pathological relevance of hemoglobin...

Descripción completa

Detalles Bibliográficos
Autores principales: Welsch, Thilo, Zschäbitz, Stefanie, Becker, Verena, Giese, Thomas, Bergmann, Frank, Hinz, Ulf, Keleg, Shereen, Heller, Anette, Sipos, Bence, Klingmüller, Ursula, Büchler, Markus W., Werner, Jens, Giese, Nathalia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148251/
https://www.ncbi.nlm.nih.gov/pubmed/21829709
http://dx.doi.org/10.1371/journal.pone.0023151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148251/
https://www.ncbi.nlm.nih.gov/pubmed/21829709
http://dx.doi.org/10.1371/journal.pone.0023151

Ejemplares similares